Detection of numerical aberrations in hematologic neoplasias by fluorescence in situ hybridization

Haematologica

Volumn 82, Issue 1, 1997, Pages 85-90

  Cuneo, Antonio ^a   Bigoni, Renato ^a   Roberti, Maria Grazia ^a   Bardi, Antonella ^a   Balsamo, Rosa ^a   Piva, Nadia ^a   Castoldi, Gianluigi ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Chromosomes; Cytogenetics; FISH; Hematologic malignancies; Leukemia; Lymphoma

Indexed keywords

ANEUPLOIDY; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL SELECTION; CELL SEPARATION; CHIMERA; CHROMOSOME ANALYSIS; DENSITY GRADIENT; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; KARYOTYPE 46,XX; KARYOTYPE 46,XY; LEUKEMIA; LYMPHOMA; MOLECULAR GENETICS; NUMERICAL CHROMOSOME ABERRATION; REVIEW;

ANEUPLOIDY; BONE MARROW TRANSPLANTATION; CELL LINEAGE; CHIMERA; CHROMOSOME ABERRATIONS; CLONE CELLS; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; MALE; NEOPLASM, RESIDUAL; SENSITIVITY AND SPECIFICITY; TUMOR STEM CELLS;

EID: 0031467114     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Le Beau MM. Fluorescence in situ hybridization in cancer diagnosis. In: De Vita VT, Hellman S, Rosenberg SA, eds. Important Advances in Oncology. Philadephia: J.B. Lippincott Co., 1993. p. 29-45.
2. Mecucci C. FISH (Fluorescent in situ hybridization): the second youth of cytogenetics. Haematologica 1995; 80:95-7.
3. Price CM. Fluorescence in situ hybridization. Blood Rev 1993; 7:127-34.
4. Weber-Mathiessen K, Deerberg J, Muller-Herelink A, Winkemann M, Schlegelberger B, Grote W. Rationalization of in situ hybridization: testing up to 16 different probes on a single slide. Cancer Genet Cytogenet 1993; 68:91-4.
5. Ward D, Lichter P. Is non-isotopic in situ hybridization finally coming of age? Nature 1990; 345:93-4.
6. Chen Z, Morgan R, Berger CS, Sandberg AA. Application of fluorescence in situ hybridization in hematological disorders. Cancer Genet Cytogenet 1992; 63:62-9.
7. Perez-Losada A, Wessman M, Tiainen M, et al. Trisomy 12 in chronic lymphocytic leukemia: an interphase cytogenetic study. Blood 1991; 78:775-9.
8. Cuneo A, Wlodarska I, Sayed A, et al. Non-radioactive in situ hybridization for the detection and monitoring of trisomy 12 in chronic lymphocytic leukaemia. Br J Haematol 1992; 81:192-6.
9. Juliusson G, Gahrton G. Cytogenetics in CLL and related disorders. In: Montserrat E, Rozman C, eds. Chronic lymphocytic leukemia. Bailliere's Clinical Haematology. London: Bailliére-Tindall 1993; 6:821-48.
10. Matutes E, Oscier D, Garcia-Marco J, et al. Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. Br J Haematol 1996; 92:382-8.
11. Raghoebier S, Kibbelaar RE, Kleiverda J, et al. Mosaicism of trisomy 12 in chronic lymphocytic leukaemia detected by non-radioactive in situ hybridization. Leukemia 1992; 6:1220-6.
12. Cuneo A, Bigoni R, Balboni M, et al. Trisomy 12 in chronic lymphocytic leukemia and hairy cell leukemia: a cytogenetic and interphase cytogenetic study. Leuk Lymphoma 1994; 15:167-72.
13. Dubinsky R, Amiel A, Manor Y, et al. Fluorescence in situ hybridization (FISH) for retrospective detection of trisomies 3 and 7 in multiple myeloma. Cancer Genet Cytogenet 1995; 83:115-8.
14. Flactif M, Zandecki M, Lai J, et al. Interphase fluorescent in situ hybridization (FISH) as a powerful tool for the detection of aneuploidy in multiple myeloma. Leukemia 1995; 9:2109-14.
15. Facon T, Lai J, Nataf E, et al. Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma: a report on 46 patients. Br J Haematol 1993; 84:743-6.
16. Cuneo A, Balsamo R, Roberti MG, et al. Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: cytologic and cytogenetic evidence in 34 patients. Cancer Genet Cytogenet 1996; 90:171-5.
17. Zandecki M, Obein V, Bernardi F, et al. Monoclonal gammopathy of undetermined significance: chromosome changes are a common finding within plasma cells. Br J Haematol 1995; 90:693-6.
18. Drach J, Angerier J, Schuster J, et al. Interphase fluorescent in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance. Blood 1995; 86:3915-21.
19. Weber-Matthiesen K, Deerberg J, Poetsch M, Grote W, Schlegelberger B. Numerical chromosome aberrations are present within the CD30+ Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin's disease. Blood 1995; 4:1464-8.
20. Lewis JP, Lanke H, Raap AK, Kibbelaar RE, Kluin PM, Kluin-Nelemans HC. Hairy cell leukemia: an interphase cytogenetic study. Leukemia 1993; 7:1334-8.
21. Haglund U, Juliusson G, Stella B, Gahrton G. Hairy cell leukemia is characterized by clonal chromosome abnormalities clustered to specific regions. Blood 1994; 83:2637-45.
22. Poddighe PJ, Moesker O, Smeets D, Awward BH, Ramaekers CS, Hopman AH. Interphase cytogenetics of hematological cancer: comparison of classical karyotyping and in situ hybridization using a panel of eleven chromosome specific DNA probes. Cancer Res 1991; 51:1959-67.
23. Jenkins RB, Le Beau MM, Kraker WJ, et al. Fluorescence in situ hybridization: a sensitive method for trisomy 8 detection in bone marrow specimens. Blood 1992; 79:3307-15.
24. Kibbelaar RE, Mulder JWR, Dreef EJ, et al. detection of monosomy 7 and trisomy 8 in myeloid neoplasia: a comparison of banding and fluorescence in situ hybridization. Blood 1993; 77:2456-62.
25. Brizard F, Brizard A, Guilhot F, Tanzer J, Berger R. Detection of monosomy 7 and trisomies 8 and 11 in myelodysplastic disorders by interphase fluorescent in situ hybridization, comparison with acute non-lymphocytic leukemias. Leukemia 1994; 8:1005-10.
26. Flactif M, Luc Lai J, Preudhomme C, Fenaux P. Fluorescence in situ hybridization improves the detection of monosomy 7 in myelodysplastic syndromes. Leukemia 1994; 8:1012-8.
27. Teerenhovi L, Knuutila S, Ekblom M, et al. A method for the simultaneous study of the karyotype, morphology, and immunological phenotype of mitotic cells in hematological malignancies. Blood 1984; 64:1116-22.
28. Weber-Matthlesen K, Winkemann M, Muller-Hermelink A, Schlegelberer B, Grote W. Simultaneous fluorescence immunophenotyping and interphase cytogenetics: a contribution to the characterization of tumor cells. J Histochem Cytochem 1992; 40:171-5.
29. Soenen V, Fenaux P, Flactif M, et al. Combined immunophenotyping and in situ hybridization (FICTION): a rapid method to study cell lineage involvement in myelodysplastic syndromes. Br J Hematol 1995; 90:701-6.
30. Dal Cin P, Aly MS, Delabie J, et al. Trisomy 7 and trisomy 10 characterize subpopulations of tumor-infiltrating lymphocytes in kidney tumors and in the surrounding kidney tissue. Proc Natl Acad Sci USA 1992; 89:9744-8.
31. Anastasi J, Feng J, Le Beau MM, Larson LA, Rowley J, Vardiman JW. Cytogenetic clonality in myelodysplastic syndromes studied with fluorescemnce in situ hybridization: lineage, response to growth factor therapy, and clone expansion. Blood 1993; 81:1580-5.
32. van Lom K, Hagemeijer A, Smit EME, Lowenberg B. In situ hybrid.ization on May-Grünwald-Giemsa-stained bone marrow and blood smears of patients with hematologic disorders allows detection of cell-lineage-specific cytogenetic anormalities. Blood 1993; 82:884-8.
33. Gerristen WR, Donohue J, Buaman J, et al. Clonal analysis of myelodysplastic syndrome: monosomy 7 is expressed in the myeloid lineage, but not in the lymphoid lineage as detected by fluorescent in situ hybridization. Blood 1992; 80:217-24.
34. Cuneo A, Balboni M, Carli MG, et al. Involvement of erythrocytic and granulomonocytic lineage by trisomy 11 in two cases of acute myelomonocytic leukemia with trilineage myelodysplasia. An interphase cytogenetic study. Cancer Genet Cytogenet 1994; 77:307-16.
35. Poddighe PJ, Van Der Lely N, Vooijs P, De Witte T, Ramaekers FCS, Hopman AHN. Interphase cytogenetics on agar cultures: a novel approach to determine chromosomal aberrations in hematopoietic stem cells. Exp Hematol 1993; 21:859-63.
36. Fagioli F, Cuneo A, Bardi A, et al. Heterogeneity of lineage involvement by trisomy 8 in myelodysplastic syndrome. Cancer Genet Cytogenet 1995; 82:116-22.
37. Coignet LJA, Van de Rijke FM, Vrolijk J, Bertheas MF, Raap AK, Tanke HJ. Automated counting of in situ hybridization dots in interphase cells of leukemia samples. Leukemia 1996; 10:1065-71.
38. White D, Crolla JA, Ross FM. Detection of minimal residual disease in childhood acute lymphoblastic leukaemia using fluorescence insitu hybridization. Br J Haematol 1995; 91:1019-24.
39. Hagemeijer A. Monitoring of residual disease in chronic myelogenous leukemia: methodological approaches and clinical aspects: comments (Debate Round Table). Leukemia 1996; 10:896-906.
40. Anastasi J, Vardiman JW, Rudinsky R, et al. Direct correlation of cytogenetic findings with cell morphology using in situ hybridization. An analysis of suspicious cells in bone marrow specimens of two patients completing therapy for acute lymphoblastic leukemia. Blood 1991; 77:2456-61.
41. Hagenbeek A, Erpelinek SLA, Martens ACM, Arkensteijin GJA. Fluorescent in situ hybridization with chromosome specific probes to detect residual leukemic cells. Exp Hematol 1992; 20:795-9.
42. Durnam DM, Anders KR, Fisher L, O'Quigley J, Bryant AM, Thomas ED. Analysis of the origin of marrow cells in bone marrow transplant recipients using a Y-chromosome-specific in situ hybridization assay. Blood 1989; 74:2220-4.
43. van Dekken H, Hagenbeek A, Bauman JG. Detection of host cells following sex-mismatched bone marrow transplantation by fluorescent in situ hybridization with a Y-chromosome specific probe. Leukemia 1989; 10:724-8.
44. Van Den Berghe D, Wessman M, Murray L, et al. Leukemic burden in subpopulations of CD34+ cells isolated from the mobilized peripheral blood of alpha-interferon-resistant or -intolerant patients with chronic myeloid leukemia. Blood 1996; 10:4348-57.
45. Rowley JD, Diaz MO, Espinoza R, et al. Mapping chromosome 11q23 in human acute leukemia with biotinylated probes: identification of 11q23 translocation breakpoints with a yeast artificial chromosome. Proc Natl Acad Sci USA 1990; 87:9358-61.
46. Bohlander SK, Espinosa R, Le Beau MM, Rowley JD, Diaz MO. A method for a rapid sequence-independent amplification of microdissected chromosomal material. Genomics 1992; 13:1322-6.
47. Heerema NA, Argyropoulus G, Weetman R, Tricot G, Secker-Walker LM. Interphase in situ hybridization reveals minimal residual disease in early remission and return of the diagnostic clone in karyotypically normal relapse of acute lymphoblastic leukemia. Leukemia 1993; 7: 537-43.
48. Anastasi J, Le Beau MM, Vardiman JW, Femald AA, Larson RA, Rowley JD. Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescent in situ hybridization to interphase cells. A simple and sensitive method. Blood 1992; 79:1796-804.
49. Kallioniemi A, Kallioniemi OP, Rutowitz D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992; 258:818-21.
50. Raap T. Cytometry for CGH [editorial]. Cytometry 1995; 19:1-3.
51. du Manoir S, Schrock E, Bentz M, et al. Quantitative analysis of comparative genomic hybridization. Cytometry 1995; 19:27-41.
52. Kallioniemi OP, Isola J. CGH and applications in cancer genetics [abstract]. Paper presented at the meeting of Comparative Genomic Hybridization, Semmering, 1996:14.
53. Bentz M, Huck K, du Manoir S, et al. Comparative genomic hybridization in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses. Blood 1995; 85:3610-8.
54. Kibbelaar RE, van Kamp H, Dreef EJ, et al. Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplastic syndrome. Blood 1992; 79: 4823-8.
55. Baurmann H, Cherif D, Berger R. Interphase cytogenetics by fluorescent in situ hybridization (FISH) for characterization of monosomy-7-associated myeloid disorders. Leukemia 1993; 7:3845-91.
56. Price CM. Fluorescence in situ hybridization. Leukemia 1993; 7: 127-34.
57. van Lom K, Hagemeier A, Vandekerckhove F, Smit EME, Lowenberg B. Cytogenetic clonality analysis. Typical patterns in myelodysplastic syndrome and acute myeloid leukemia. Br J Haematol 1996; 93: 594-600.
58. Anastasi J, Feng J, Le Beau MM, Larson RA, Rowley JD, Wardiman JW. The relationship between secondary chromosomal abnormalities and blast transformation in chronic myelogenous leukemia. Leukemia 1995; 9:628-33.
59. Nguyen PL, Athur DC, Litz CE, Brunning RD. Fluorescence in situ hybridization (FISH) detection of trisomy 8 in myeloid cells in chronic myeloid leukemia (CML). A study of archival blood and bone marrow smears. Leukemia 1994; 8:1654-62.
60. Mehrotra B, George TI, Kavanau K, et al. Cycogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemia. Blood 1995; 86:1139-47.
61. Fugazza G, Lerza R, Bruzzone R, Sessarego M. Clonality study by fluorescence in situ hybridization of a patient with refractory anemia with ringed sideroblasts and monosomy 7. Haematologica 1995; 80:54-7.